It will be important to thoroughly characterize the different TMEM106B knockout models to allow robust evaluation of the in vivo effects of TMEM106B levels in C9ALS/FTD as well as progranulin FTD mouse models. The gene discussed is TMEM106B; the disease is frontotemporal dementia.